Incidence of Acute Kidney Injury in Relapsed and Refractory Multiple Myeloma treated with Teclistamab versus CAR T-cells. #MayoClinicKidney @mariacharkviani @delphile  @Arjun_Mohan1 @mvargas07 @YiLinMDPhD @HerrmannMd @NDTsocial